1462-1463 / 2953
Oesophageal tumours
• 50Gy with concurrent chemo
• Cervical oesophageal tumours
•
Spinal cord sparing
• Lung sparing (mean dose)
• Heart sparing (V30, V45)
• Clinical benefit?
• Less cardiac deaths
Nicolini et al IJROBP 2012;84(2):553. Lin et al IJROBP;84(5):1078